The biopharmaceutical industry is undergoing significant changes, driven by the growing integration of artificial intelligence (AI) and automation. These technologies are not only transforming internal processes but also redefining market strategies. Sartorius Stedim Biotech, in partnership with Jungheinrich, has demonstrated the impact of logistics automation, while Merck and Google Cloud are heavily investing in agentic AI. These initiatives illustrate a trend towards greater operational efficiency and accelerated innovation, although challenges remain, particularly regarding data reliability.
Débloquez l'Analyse Complète
Accédez instantanément à nos insights exclusifs générés par IA, basés sur l'agrégation de centaines de sources sectorielles.
